Cargando…
THU402 New Heterotopic Ossification Lesions In Patients With Fibrodysplasia Ossificans Progressiva Measured By PET/CT vs CT Only
Disclosure: D. Gonzalez Trotter: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. J. McGinniss: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Self; Regeneron Pharmaceuticals. A.N. Economides: Employee; Self; Regeneron Pharmaceuticals. Stock Owner; Se...
Autores principales: | Trotter, Dinko Gonzalez, McGinniss, Jennifer, Economides, Aris N, Mohammadi, Kusha, Rankin, Andrew J, Musser, Bret, Mellis, Scott, Forleo-Neto, Eduardo, Herman, Gary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554180/ http://dx.doi.org/10.1210/jendso/bvad114.365 |
Ejemplares similares
-
OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data
por: Dahir, Kathryn M, et al.
Publicado: (2023) -
THU467 Pharmacokinetics And Pharmacodynamics Of Garetosmab In Patients With Fibrodysplasia Ossificans Progressiva
por: Wang, Yuhuan, et al.
Publicado: (2023) -
An mTOR Signaling Modulator Suppressed Heterotopic Ossification of Fibrodysplasia Ossificans Progressiva
por: Hino, Kyosuke, et al.
Publicado: (2018) -
Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery
por: Yang, Yeon-Suk, et al.
Publicado: (2022) -
Microarchitecture of Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva: An HR-pQCT Case Series
por: Botman, Esmée, et al.
Publicado: (2021)